Galenea's Unattributed Round

Galenea raised a round of funding on April 26, 2012. Investors include Stanley Medical Research Institute.

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, A…

Articles about Galenea's Unattributed Round: